<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00860314</url>
  </required_header>
  <id_info>
    <org_study_id>UKE-2383</org_study_id>
    <nct_id>NCT00860314</nct_id>
  </id_info>
  <brief_title>Antero-posterior Versus Antero-lateral Electrode Position for Electrical Cardioversion of Typical Atrial Flutter</brief_title>
  <acronym>APOVERSAL</acronym>
  <official_title>Prospective, Randomized Single-center Study for Efficacy of Antero-posterior and Antero-lateral Electrode Position for External Electrical Cardioversion of Typical Atrial Flutter</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to identify the one electrode position out of two most commonly used
      for external electrical cardioversion of typical atrial flutter, which needs less delivered
      energy and less needed number of shocks for successful cardioversion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Typical atrial flutter is the second-most prevalent atrial tachyarrhythmia. No guidelines for
      treatment exist and few studies investigate treatment of atrial flutter. Mostly, guidelines
      for atrial fibrillation are followed for treatment of atrial flutter. Atrial flutter has a
      different pathomechanism as atrial fibrillation, therefore special guidelines for treatment
      are needed. Among drug treatment and ablation procedures, external electrical cardioversion
      is commonly used, especially for treatment of acute symptomatic patients. This study may help
      to further define safe and successful procedures for electrical cardioversion of atrial
      flutter.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Statistical interim analysis showed valid and significant results
  </why_stopped>
  <start_date>January 2005</start_date>
  <completion_date type="Actual">December 2005</completion_date>
  <primary_completion_date type="Actual">December 2005</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Successfully Cardioverted Participants for Each Electrode Position</measure>
    <time_frame>30 seconds after cardioversion</time_frame>
    <description>After restoration of normal sinus rhythm for 30 seconds and longer by electrical countershock a cardioversion is counted as successful.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Number of Cardioversion Shocks</measure>
    <time_frame>30 seconds after cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Energy Requirement for Successful Cardioversion</measure>
    <time_frame>30 seconds after cardioversion</time_frame>
    <description>Overall energy in the mean (number of joules) necessary for successful cardioversion of all patients per group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Succesfully Cardioverted With First Shock in Each Electrode Position</measure>
    <time_frame>30 seconds after cardioversion</time_frame>
    <description>Number of participants successfully cardioverted to normal sinus rhythm with one shock of 50 Joules.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">96</enrollment>
  <condition>Atrial Flutter</condition>
  <arm_group>
    <arm_group_label>AP Position</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cardioversion with antero-posterior electrode position</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AL Position</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cardioversion with antero-lateral electrode position</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>external electrical cardioversion (with antero-posterior electrode position)</intervention_name>
    <description>external biphasic electrical cardioversion with step-up-protocol of 50-75-100-150-200 Joules if necessary with antero-posterior electrode position until restoration of normal sinus rhythm</description>
    <arm_group_label>AP Position</arm_group_label>
    <other_name>biphasic cardioversion</other_name>
    <other_name>countershock treatment</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>external electrical cardioversion (with antero-lateral electrode position)</intervention_name>
    <description>external biphasic electrical cardioversion with step-up protocol of 50-75-100-150-200 Joules if necessary with antero-lateral electrode position until restoration of normal sinus rhythm</description>
    <arm_group_label>AL Position</arm_group_label>
    <other_name>biphasic cardioversion</other_name>
    <other_name>countershock treatment</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical diagnosis of typical atrial flutter

          -  signed written informed consent

          -  eligibility for sedation and external electrical cardioversion

        Exclusion Criteria:

          -  clinical diagnosis of arrhythmia other than typical atrial flutter

          -  implanted ICD or pacemaker

          -  proof of atrial thrombi
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephan Willems, Prof. Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Oberarzt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Hamburg-Eppendorf, Heart Center</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.uke.de</url>
    <description>Homepage of University Hospital Hamburg-Eppendorf</description>
  </link>
  <reference>
    <citation>Kerber RE, Kouba C, Martins J, Kelly K, Low R, Hoyt R, Ferguson D, Bailey L, Bennett P, Charbonnier F. Advance prediction of transthoracic impedance in human defibrillation and cardioversion: importance of impedance in determining the success of low-energy shocks. Circulation. 1984 Aug;70(2):303-8.</citation>
    <PMID>6733884</PMID>
  </reference>
  <reference>
    <citation>Kirchhof P, Eckardt L, Loh P, Weber K, Fischer RJ, Seidl KH, Böcker D, Breithardt G, Haverkamp W, Borggrefe M. Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial. Lancet. 2002 Oct 26;360(9342):1275-9.</citation>
    <PMID>12414201</PMID>
  </reference>
  <reference>
    <citation>Kirchhof P, Borggrefe M, Breithardt G. Effect of electrode position on the outcome of cardioversion. Card Electrophysiol Rev. 2003 Sep;7(3):292-6. Review.</citation>
    <PMID>14739731</PMID>
  </reference>
  <reference>
    <citation>Kerber RE, Jensen SR, Grayzel J, Kennedy J, Hoyt R. Elective cardioversion: influence of paddle-electrode location and size on success rates and energy requirements. N Engl J Med. 1981 Sep 17;305(12):658-62.</citation>
    <PMID>7266602</PMID>
  </reference>
  <reference>
    <citation>Botto GL, Politi A, Bonini W, Broffoni T, Bonatti R. External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements. Heart. 1999 Dec;82(6):726-30.</citation>
    <PMID>10573502</PMID>
  </reference>
  <reference>
    <citation>Yoon RS, DeMonte TP, Hasanov KF, Jorgenson DB, Joy ML. Measurement of thoracic current flow in pigs for the study of defibrillation and cardioversion. IEEE Trans Biomed Eng. 2003 Oct;50(10):1167-73.</citation>
    <PMID>14560770</PMID>
  </reference>
  <reference>
    <citation>Van Gelder IC, Tuinenburg AE, Schoonderwoerd BS, Tieleman RG, Crijns HJ. Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation. Am J Cardiol. 1999 Nov 4;84(9A):147R-151R. Review.</citation>
    <PMID>10568674</PMID>
  </reference>
  <reference>
    <citation>Kerber RE. Transthoracic cardioversion of atrial fibrillation and flutter: standard techniques and new advances. Am J Cardiol. 1996 Oct 17;78(8A):22-6. Review.</citation>
    <PMID>8903272</PMID>
  </reference>
  <reference>
    <citation>Camacho MA, Lehr JL, Eisenberg SR. A three-dimensional finite element model of human transthoracic defibrillation: paddle placement and size. IEEE Trans Biomed Eng. 1995 Jun;42(6):572-8.</citation>
    <PMID>7790013</PMID>
  </reference>
  <reference>
    <citation>Kirchhof P, Mönnig G, Wasmer K, Heinecke A, Breithardt G, Eckardt L, Böcker D. A trial of self-adhesive patch electrodes and hand-held paddle electrodes for external cardioversion of atrial fibrillation (MOBIPAPA). Eur Heart J. 2005 Jul;26(13):1292-7. Epub 2005 Feb 25.</citation>
    <PMID>15734772</PMID>
  </reference>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2008</study_first_submitted>
  <study_first_submitted_qc>March 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 12, 2009</study_first_posted>
  <results_first_submitted>November 10, 2008</results_first_submitted>
  <results_first_submitted_qc>March 11, 2009</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 12, 2009</results_first_posted>
  <last_update_submitted>August 17, 2015</last_update_submitted>
  <last_update_submitted_qc>August 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsklinikum Hamburg-Eppendorf</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Stephan Willems</investigator_full_name>
    <investigator_title>Ltd. Oberarzt des Universitären Herzzentrums Hamburg</investigator_title>
  </responsible_party>
  <keyword>external electrical cardioversion</keyword>
  <keyword>typical atrial flutter</keyword>
  <keyword>electrode position</keyword>
  <keyword>antero-lateral</keyword>
  <keyword>antero-posterior</keyword>
  <keyword>biphasic cardioversion</keyword>
  <keyword>step-up protocol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Flutter</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Antero-Posterior Group</title>
          <description>Cardioversion with antero-posterior electrode position</description>
        </group>
        <group group_id="P2">
          <title>Antero-Lateral Group</title>
          <description>Cardioversion with antero-lateral electrode position</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="48"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="48"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Antero-Posterior Group</title>
          <description>Cardioversion with antero-posterior electrode position</description>
        </group>
        <group group_id="B2">
          <title>Antero-Lateral Group</title>
          <description>Cardioversion with antero-lateral electrode position</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="48"/>
            <count group_id="B2" value="48"/>
            <count group_id="B3" value="96"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62" spread="12.18"/>
                    <measurement group_id="B2" value="62" spread="12.53"/>
                    <measurement group_id="B3" value="62" spread="12.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="48"/>
                    <measurement group_id="B3" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Secondary</type>
        <title>Mean Number of Cardioversion Shocks</title>
        <time_frame>30 seconds after cardioversion</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Antero-Posterior Group</title>
            <description>Cardioversion with antero-posterior electrode position</description>
          </group>
          <group group_id="O2">
            <title>Antero-Lateral Group</title>
            <description>Cardioversion with antero-lateral electrode position</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Number of Cardioversion Shocks</title>
          <units>Shocks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.96" spread="1.00"/>
                    <measurement group_id="O2" value="1.48" spread="1.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Successfully Cardioverted Participants for Each Electrode Position</title>
        <description>After restoration of normal sinus rhythm for 30 seconds and longer by electrical countershock a cardioversion is counted as successful.</description>
        <time_frame>30 seconds after cardioversion</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Antero-Posterior Group</title>
            <description>Cardioversion with antero-posterior electrode position</description>
          </group>
          <group group_id="O2">
            <title>Antero-Lateral Group</title>
            <description>Cardioversion with antero-lateral electrode position</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Successfully Cardioverted Participants for Each Electrode Position</title>
          <description>After restoration of normal sinus rhythm for 30 seconds and longer by electrical countershock a cardioversion is counted as successful.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48"/>
                    <measurement group_id="O2" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Energy Requirement for Successful Cardioversion</title>
        <description>Overall energy in the mean (number of joules) necessary for successful cardioversion of all patients per group.</description>
        <time_frame>30 seconds after cardioversion</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Antero-Posterior Group</title>
            <description>Cardioversion with antero-posterior electrode position</description>
          </group>
          <group group_id="O2">
            <title>Antero-Lateral Group</title>
            <description>Cardioversion with antero-lateral electrode position</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Energy Requirement for Successful Cardioversion</title>
          <description>Overall energy in the mean (number of joules) necessary for successful cardioversion of all patients per group.</description>
          <units>Joules</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77" spread="13"/>
                    <measurement group_id="O2" value="65" spread="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Succesfully Cardioverted With First Shock in Each Electrode Position</title>
        <description>Number of participants successfully cardioverted to normal sinus rhythm with one shock of 50 Joules.</description>
        <time_frame>30 seconds after cardioversion</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Antero-Posterior Group</title>
            <description>Cardioversion with antero-posterior electrode position</description>
          </group>
          <group group_id="O2">
            <title>Antero-Lateral Group</title>
            <description>Cardioversion with antero-lateral electrode position</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Succesfully Cardioverted With First Shock in Each Electrode Position</title>
          <description>Number of participants successfully cardioverted to normal sinus rhythm with one shock of 50 Joules.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Antero-Posterior Group</title>
          <description>Cardioversion with antero-posterior electrode position</description>
        </group>
        <group group_id="E2">
          <title>Antero-Lateral Group</title>
          <description>Cardioversion with antero-lateral electrode position</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="48"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="48"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Tim Risius, MD</name_or_title>
      <organization>University Hospital Hamburg-Eppendorf, Heart Center</organization>
      <phone>+49-40-42803 ext 4142</phone>
      <email>risius@uke.uni-hamburg.de</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

